Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Guttman, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Guttman, M; Jaskolka, J
      The use of pramipexole in Parkinson's disease: are its actions D-3 mediated?

      PARKINSONISM & RELATED DISORDERS
    2. Abbruzzese, G; Agid, Y; Albanese, A; Alf, C; Allen, R; Amar, K; de Andrade, LA; Ang, LC; Angelini, C; Archer, RL; Arunodaya, GR; Baltzan, M; Baral, K; Barnett, H; Bergamasco, B; Berger, M; Bernard, J; Bharucha, NE; Bhatia, K; Blary, N; Black, S; Bodis-Wollner, I; Boyson, SJ; Bral-Kulaksizoglu, I; Brooks, DJ; Brown, JD; Burke, RE; Calne, DOC; Calne, SM; Cardoso, F; Cardozo-Pelaez, F; Chang, YJ; Chen, CC; Chen, RS; Chen, R; Chowdhury, A; Christie, S; Chu, CC; Chu, NS; Clarida, L; Collette, EM; Comella, C; Conneally, PM; Crossman, AR; Csanda, E; Dalmau, J; Dalvi, A; De Feijter, A; Deecke, L; Desai, H; De Ybenes, J; Dihenia, B; Direnfeld, L; Dodel, R; Donat, J; Doudet, D; Duane, DD; Duff, J; Duvoisin, R; Eggert, K; Elble, RJ; Elmer, LW; Emre, M; Fariello, R; Fernendy, HH; Findley, LJ; Fink, S; Freissmuth, M; Friedman, JH; de la Fuente-Fernandez, R; Furtado, S; Furukawa, Y; Galvez-Jimenez, N; Gauthier, S; Gawel, MJ; Gilman, S; Gladstone, RM; Goetz, CG; Gomori, A; Gopinathan, G; Gordin, A; Gorell, JM; Greenamyre, JT; Grimes, DA; Gurvit, H; Guttman, M; Guzman, DA; Hachinski, V; Hanagasi, H; Hardy, J; Harik, SJ; Hassan, MN; Hattori, N; Hauser, RA; Hayashi, H; Heller, GL; Hobson, D; Hochschorner, G; Hortnagel, H; Horowski, R; Howse, DC; Huang, CC; Huk, II; Hurtig, H; Hutton, JT; Jaffe, ME; Jankovic, J; Jardine, M; Jog, M; Johnson, B; Kagamihara, Y; Karagoz, N; Kasper, S; Kato, S; Kebabian, JW; Kertsz, A; Khadilkar, SV; Kirk, A; Kish, S; Kitaguchi, T; Kofman, OS; Koide, R; Komori, T; Kostyuk, PG; Kumar, R; Kuo, HC; Kurlan, R; Kurland, L; Kurtuncu, M; Lalkaka, JA; Lambert, M; Landau, W; Lang, AE; Lassmann, H; Lee, CS; Lees, AJ; Lieberman, A; Litvan, I; Loeb, C; Logan, WJ; Lozano, AM; Lu, CS; Lucy, D; Lynch, T; Manyam, BV; Maraganore, D; Marshall, FT; Martin, WRW; Martin, WE; Mathias, C; Matsubera, S; Mendis, T; Menkes, JH; Metz, LN; Miyazaki, Y; Mizuno, Y; Mohr, E; Moodley, LG; Moore, R; Morris, JL; Muthane, U; Nagaraja, D; Nair, CPV; Narabayashi, H; Nomura, Y; Norris, JW; Obeso, JA; O'Brien, C; Oertel, W; Ohtake, T; Okiyama, R; Ozdemir, C; Pal, PK; Panisset, M; Paty, DW; Paulson, GW; Perlmutter, J; Pfeiffer, RF; Pifl, C; Pincus, JH; Poewe, W; Quinn, N; Rajput, AH; Rajput, A; Ransmayr, G; Rascol, O; Robinson, R; Rocca, WA; Roos, RAC; Rosenfeld, MR; Russell, D; Ruth, TJ; Ryu, SJ; Sachdev, H; Safoschnik, G; Sahin, H; Sanchez-Ramos, J; Satishchandra, P; Schapira, A; Scheltens; Schmidley, JW; Schnaberth, G; Schneider, E; Schneider, JS; Schutz, W; Seeberger, LC; Segawa, M; Sethi, KD; Shah, A; Shannon, K; Shelton, P; Shihabuddin, B; Shimizu, T; Shinotoh, H; Siddique, T; Siderowf, A; Sieghart, W; Simard, A; Simmonds, DC; Singhal, BS; Sluga, E; Snow, BJ; Soukop, W; Sperk, G; Spieker, S; Steele, JC; Stewart, S; Stoessl, AJ; Subramony, SH; Sundaram, M; Sung, CY; Surya, N; Sweet, RD; Tabbal, SD; Takahashi, H; Taniguchi, M; Tarsy, D; Teravainen, H; Tetrud, JW; Tolosa, E; Tourtellotte, WW; Troupin, AS; Tsui, JKC; Tuite, P; Uc, EY; Ueki, Y; Uitti, R; Uyu, C; van Hilten, JJ; Veerendrakumar, M; Veloso, F; Viallet, F; Voll, C; Vrooman, M; Wang, X; Ward, I; Ward, A; Waters, C; Weng, YH; Wenning, GK; Williams, BJ; Wilson, TW; Wolters, EC; Wooten, FG; Wszolek, Z; Yahr, MD; Yanagisawa, N; Yokochi, F; Young, RR; Yu, CM; Zifko, U
      An open letter to the Committee on the Nobel Prize in Medicine

      PARKINSONISM & RELATED DISORDERS
    3. Kish, SJ; Kalasinsky, KS; Derkach, P; Schmunk, GA; Guttman, M; Ang, L; Adams, V; Furukawa, Y; Haycock, JW
      Striatal dopaminergic and serotonergic markers in human heroin users

      NEUROPSYCHOPHARMACOLOGY
    4. Kalasinsky, KS; Bosy, TZ; Schmunk, GA; Reiber, G; Anthony, RM; Furukawa, Y; Guttman, M; Kish, SJ
      Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users

      FORENSIC SCIENCE INTERNATIONAL
    5. DeStefano, AL; Golbe, LI; Mark, MH; Lazzarini, AM; Maher, NE; Saint-Hilaire, M; Feldman, RG; Guttman, M; Watts, RL; Suchowersky, O; Lafontaine, AL; Labelle, N; Lew, MF; Waters, CH; Growdon, JH; Singer, C; Currie, LJ; Wooten, GF; Vieregge, P; Pramstaller, PP; Klein, C; Hubble, JP; Stacy, M; Montgomery, E; MacDonald, ME; Gusella, JF; Myers, RH
      Genome-wide scan for Parkinson's disease: The GenePD study

      NEUROLOGY
    6. Paulsen, JS; Zhao, H; Stout, JC; Brinkman, RR; Guttman, M; Ross, CA; Como, P; Manning, C; Hayden, MR; Shoulson, I
      Clinical markers of early disease in persons near onset of Huntington's disease

      NEUROLOGY
    7. Kieburtz, K; Koroshetz, W; McDermott, M; Beal, MF; Greenamyre, JT; Ross, CA; Shoulson, I; Cudkowicz, ME; Sexton, P; Skeuse, C; Rosas, D; Jenkins, B; Rosenblatt, A; Sherr, M; Hersch, S; Cellar, J; Guttman, M; Brown, C; Como, PG; Marshall, F; DeMarcaida, JA; Zimmerman, C; Marder, K; Moskowitz, C; Polanco, C; Beltre, J; Shannon, K; Jaglin, JA; Niederman, F; Ashizawa, T; Hunter, C; Hunter, C; Hauser, R; Walker, A; Gauger, L; Hahn, MA; Delgado, H; Dawson, T; Siemers, E; Seeberger, L; Dingmann, C; Dubinsky, R; Gray, C; Weiner, WJ; Rodriguez-Batemen, D; Albin, RL; Wernette, K; Harrison, M; Rost-Ruffner, E; Paulsen, J; Rodnitzky, RL; Dobson, J; Vining, L; Suchowersky, O; Pantella, C; Saint-Hilaire, MH; Furtado, J; Martin, W; Wieler, M; Walker, F; Hunt, V; Raymond, L; Almqvist, E; Rubin, A; Blair, B; Marek, K; Caplan, K; Baker, D; Brocht, A; Casaceli, C; Orme, C; Rudolph, A; Rumfola, L; Schifitto, G; Shinaman, A; Sulimowicz, K; Watts, A; Eapen, S; Zhang, L
      A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease

      NEUROLOGY
    8. Guttman, M; Stewart, D; Hussey, D; Wilson, A; Houle, S; Kish, S
      Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD

      NEUROLOGY
    9. Kish, SJ; Kalasinsky, KS; Schmunk, G; Furukawa, Y; Guttman, M; Ang, L
      Dopaminergic changes in human brain following acute exposure to gamma-hydroxybutyrate

      NEUROLOGY
    10. Worsley, JN; Moszczynska, A; Falardeau, P; Kalasinsky, KS; Schmunk, G; Guttman, M; Furukawa, Y; Ang, L; Adams, V; Reiber, G; Anthony, RA; Wickham, D; Kish, SJ
      Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users

      MOLECULAR PSYCHIATRY
    11. Furukawa, Y; Guttman, M; Sparagana, SP; Trugman, JM; Hyland, K; Wyatt, P; Lang, AE; Rouleau, GA; Shimadzu, M; Kish, SJ
      Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolaseI gene

      ANNALS OF NEUROLOGY
    12. Kalasinsky, KS; Bosy, TZ; Schmunk, GA; Ang, L; Adams, V; Gore, SB; Smialek, J; Furukawa, Y; Guttman, M; Kish, SJ
      Regional distribution of cocaine in postmortem brain of chronic human cocaine users

      JOURNAL OF FORENSIC SCIENCES
    13. Kish, SJ; Kalasinsky, KS; Furukawa, Y; Guttman, M; Ang, L; Li, L; Adams, V; Reiber, G; Anthony, RA; Anderson, W; Smialek, J; DiStefano, L
      Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin

      MOLECULAR PSYCHIATRY
    14. Guttman, M; Suchowersky, O
      Parkinson's disease management: Towards a new paradigm

      CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
    15. LEGER G; GJEDDE A; KUWABARA H; GUTTMAN M; CUMMING P
      EFFECT OF CATECHOL-O-METHYLTRANSFERASE INHIBITION ON BRAIN UPTAKE OF [F-18] FLUORODOPA - IMPLICATIONS FOR COMPARTMENTAL MODELING AND CLINICAL USEFULNESS

      Synapse
    16. CROISILLE P; JANIER M; GUTTMAN M; REVEL D
      COMPARISON OF DOBUTAMINE STRESS TAGGED MRI WITH F-18 FDG PET TO ASSESS MYOCARDIAL VIABILITY IN PATIENTS WITH CHRONIC ISCHEMIC-HEART-DISEASE

      Journal of the American College of Cardiology
    17. HUSSEY D; STEWART D; HOULE S; GUTTMAN M
      [C-11] RACLOPRIDE STRIATAL BINDING POTENTIAL AS A MEASURE OF HUNTINGTONS-DISEASE PROGRESSION - IMPLICATIONS FOR PROSPECTIVE NEUROPROTECTIVESTUDIES

      The Journal of nuclear medicine
    18. STEWART DJ; HUSSEY D; JONES C; HOULE S; THOMSON J; GUTTMAN M
      PET STUDIES IN PRESYMPTOMATIC AND SYMPTOMATIC HUNTINGTONS-DISEASE PATIENTS COMPARISON [F-18] FLUORODEOXYGLUCOSE, [C-11] RACLOPRIDE AND [C-11] SCH-23390

      Neurology
    19. FURUKAWA Y; LANG AE; TRUGMAN JM; BIRD TD; HUNTER A; SADEH M; TAGAWA T; STGEORGEHYSLOP PH; GUTTMAN M; MORRIS LW; HORNYKIEWICZ O; SHIMADZU M; KISH SJ
      GENDER-RELATED PENETRANCE AND DE-NOVO GTP-CYCLOHYDROLASE-I GENE-MUTATIONS IN DOPA-RESPONSIVE DYSTONIA

      Neurology
    20. KISH SJ; LOPESCENDES I; GUTTMAN M; FURUKAWA Y; PANDOLFO M; ROULEAU GA; ROSS BM; NANCE M; SCHUT L; ANG L; DISTEFANO L
      BRAIN GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-ACTIVITY IN HUMAN TRINUCLEOTIDE REPEAT DISORDERS

      Archives of neurology
    21. TAYLOR RP; FERGUSON PJ; MARTIN EN; COOKE J; GREENE KL; GRINSPUN K; GUTTMAN M; KUHN S
      IMMUNE-COMPLEXES BOUND TO THE PRIMATE ERYTHROCYTE COMPLEMENT RECEPTOR(CR-1) VIA ANTI-CR-1 MABS ARE CLEARED SIMULTANEOUSLY WITH LOSS OF CR-1 IN A CONCERTED REACTION IN A RHESUS-MONKEY MODEL

      Clinical immunology and immunopathology
    22. CROISILLE P; JANIER M; GUTTMAN M; REVEL D
      DOBUTAMINE STRESS TAGGED MRI TO ASSESS MYOCARDIAL VIABILITY IN PATIENTS WITH CHRONIC ISCHEMIC-HEART-DISEASE - COMPARISON WITH F-18 FDG PET

      Radiology
    23. GUTTMAN M; OTT E; TRAGNER H; BEDARD PJ; POURCHER E; CURRAN T; GOODRIDGE A; GUTTMAN M; HOBSON D; KING D; MARTIN WRW; MENDIS T; RAJPUT A; RIVEST J; STOESSL J; SUCHOWERSKY O; MORAN J; MURPHY R; WALSH B; ONEILL DO; KLEMPERER B; MARTIN M; OEHLWEIN C; POLZER U; REICHMANN H; SCHIMEK J; SCHLENKER M; SCHWARTZ A; MEIER D; TRAUBNER P; BENETIN J; BOMHOF MAM; HOVESTADT A; VREELING FW; WOLTERS ECMJ; BRODDIE HG; CLARKE C; CLOUGH CJ; LOIZOU L; NEWMAN PK; PYE IF
      DOUBLE-BLIND COMPARISON OF PRAMIPEXOLE AND BROMOCRIPTINE TREATMENT WITH PLACEBO IN ADVANCED PARKINSONS-DISEASE

      Neurology
    24. GUTTMAN M; BURKHOLDER J; KISH SJ; HUSSEY D; WILSON A; DASILVA J; HOULE S
      [C-11] RTI-32 PET STUDIES OF THE DOPAMINE TRANSPORTER IN EARLY DOPA-NAIVE PARKINSONS-DISEASE - IMPLICATIONS FOR THE SYMPTOMATIC THRESHOLD

      Neurology
    25. KISH SJ; GUTTMAN M; ROBITAILLE Y; ELAWAR M; CHANG LJ; LEVEY AI
      STRIATAL DOPAMINE NERVE-TERMINAL MARKERS BUT NOT NIGRAL CELLULARITY ARE REDUCED IN SPINOCEREBELLAR ATAXIA TYPE-1

      Neurology
    26. GUTTMAN M
      DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO COMPARE THE SAFETY, TOLERANCE AND EFFICACY OF PRAMIPEXOLE AND BROMOCRIPTINE IN ADVANCED PARKINSONS-DISEASE

      Neurology
    27. KIEBURTZ K; PENNEY JB; COMO P; RANEN N; SHOULSON I; FEIGIN A; ABWENDER D; GREENAMYRE JT; HIGGINS D; MARSHALL FJ; GOLDSTEIN J; STEINBERG K; SHIH C; RICHARD I; HICKEY C; ZIMMERMAN C; ORME C; CLAUDE K; OAKES D; SAX DS; KIM A; HERSCH S; JONES R; AUCHUS A; OLSEN D; BISSEYBLACK C; RUBIN A; SCHWARTZ R; DUBINSKY R; MALLONEE W; GRAY C; GODFREY N; SUTER G; SHANNON KM; STEBBINS GT; JAGLIN JA; MARDER K; TAYLOR S; LOUIS E; MOSKOWITZ C; THORNE D; ZUBIN N; WEXLER N; SWENSON MR; PAULSEN J; SWERDLOW N; ALBIN R; WERNETTE C; WALKER F; HUNT V; ROOS RAC; YOUNG AB; KOROSHETZ W; BIRD E; MEYERS R; CUDKOWICZ M; GUTTMAN M; STCYR J; BURKHOLDER J; LUNDIN A; ASHIZAWA T; JANKOVIC J; SIEMERS E; QUAID K; MARTIN W; SANCHEZRAMOS J; FACCA A; REY G; SUCHOWERSKY O; ROHS G; KLINEK ML; ROSS C; BYLSMA FW; SHERR M; HAYDEN M; RAYMOND L; CLARK C; KREMER B
      UNIFIED HUNTINGTONS-DISEASE RATING-SCALE - RELIABILITY AND CONSISTENCY

      Movement disorders
    28. PRZEDBORSKI S; DONALDSON D; JAKOWEC M; KISH SJ; GUTTMAN M; ROSOKLIJA G; HAYS AP
      BRAIN SUPEROXIDE-DISMUTASE, CATALASE, AND GLUTATHIONE-PEROXIDASE ACTIVITIES IN AMYOTROPHIC-LATERAL-SCLEROSIS

      Annals of neurology
    29. WILSON JM; LEVEY AI; RAJPUT A; ANG L; GUTTMAN M; SHANNAK K; NIZNIK HB; HORNYKIEWICZ O; PIFL C; KISH SJ
      DIFFERENTIAL CHANGES IN NEUROCHEMICAL MARKERS OF STRIATAL DOPAMINE NERVE-TERMINALS IN IDIOPATHIC PARKINSONS-DISEASE

      Neurology
    30. GUTTMAN M; BURKHOLDER J; KISH S; WILSON A; HOULE S
      [C-11] RTI-32 PET STUDIES OF THE DOPAMINE TRANSPORTER IN EARLY DOPA-NAIVE PARKINSONS-DISEASE

      Neurology
    31. KUWABARA H; CUMMING P; YASUHARA Y; LEGER GC; GUTTMAN M; DIKSIC M; EVANS AC; GJEDDE A
      REGIONAL STRIATAL DOPA TRANSPORT AND DECARBOXYLASE ACTIVITY IN PARKINSONS-DISEASE

      The Journal of nuclear medicine
    32. GUTTMAN M; LEGER G; RECHES A; EVANS A; KUWABARA H; CEDARBAUM JM; GJEDDE A
      ADMINISTRATION OF THE NEW COMT INHIBITOR OR-611 INCREASES STRIATAL UPTAKE OF FLUORODOPA

      Movement disorders
    33. GJEDDE A; LEGER GC; CUMMING P; YASUHARA Y; EVANS AC; GUTTMAN M; KUWABARA H
      STRIATAL L-DOPA DECARBOXYLASE ACTIVITY IN PARKINSONS-DISEASE IN-VIVO - IMPLICATIONS FOR THE REGULATION OF DOPAMINE SYNTHESIS

      Journal of neurochemistry
    34. JOEL M. GUTTMAN; SHMUEL NITZAN; URIEL SPIEGEL
      Rent Seeking and Social Investment in Taste Change

      Economics and politics
    35. JOEL M. GUTTMAN
      The Credibility Game: Reputation and Rational Cooperation in a Changing Population

      Journal of comparative economics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 18:33:40